By 2033, the Electrophysiology Market is expected to be worth US$22.67 billion, growing at a CAGR of 11.6%, according to FMI. The market is expanding quickly, and in 2023 it’s anticipated to be worth $7.57 billion.
The increasing demand for minimally invasive, safer, and efficient electrophysiology therapies has transcended electrophysiology market growth. The latest electrophysiology catheters, devices and access devices offer advanced cardiac electromapping, ablations and diagnostic procedures. The next-generation electrophysiology devices offer minimal invasive interventions that offer short hospital stay period.
Download our Sample Report to discover how recent industry developments @ https://www.futuremarketinsights.com/reports/sample/rep-gb-12402
The increasing adoption of the ablation catheterization for the management of the cardiac arrhythmias is escalated by the introduction of advanced, safer and efficient electrophysiology solutions by the key players. The minimally invasive nature of the incoming electrophysiology solutions is safer for patients with medical comorbidities.
The cardiac arrhythmia treatment regime is frequently combining these latest electrophysiology devices with several antiarrhythmic drugs such as procainamide, amiodarone, flecainide and others. The shift towards the increased adoption of the disposable catheters due to their affordability, sterility and safety has also rocketed the sales of the electrophysiology market. Manufacturers have eyed on the acquisitions, collaborations, product approvals and launching into various geographies to penetrate deep into the potential electrophysiology markets.
The COVID19 pandemic in the first few months of 2020 has imparted a negative impact on the electrophysiology market. The massive global lockdown, along with the shutting down of the economies such as China has halted the demand and supply activities. Seeing the massive influx of the COVID19 patients and the risk of hospital-acquired infections, several cardiology and electrophysiology committees jotted updated strategies and protocols of conduct to cut down on the number of electrophysiology procedures and to only perform the interventional procedures for the high priority cases.
Key Takeaways from Electrophysiology Market Study
- The global electrophysiology market is estimated to be US$ 7.84 Bn in 2020, exhibiting a CAGR of ~12.7 % during the forecast period (2020-2030)
- The U.S. will remain a highly lucrative market, accounting for over 95% of North America market in 2021, based on volume
- Demand from U.K. is poised to surge considerably. FMI forecasts it to exhibit 8.5% Y-o-Y growth in 2021
- Germany and France will emerge as other key markets for electrophysiology in the U.K.
- Demand from both Japan and South Korea is expected to increase at a considerable pace in the coming years
Your Questions, Expert Answers: Ask the Experts Today! @ https://www.futuremarketinsights.com/ask-question/rep-gb-3356
Who is winning?
The leading manufactures have eyed in the improvisation of the ablation procedures with the introduction of the latest contact-force sensing technology that offers high precision ablation, irrigated tip ablation catheters with controlled and target specific ablation and balloon catheters with more predictable and reproducible ablation.
Stereotaxis and Acutus Medical have introduced telerobotics in the cardiac ablation catheter surgeries that offer high precision ablation, real-time cardiac imaging and high-resolution cardiac mapping. Digital cloud technology has also been integrated into the Electrophysiology Devices that allows the interventionalist to remotely access the cardiac data.
For instance, J&J’s Biosense Webster launched a new cloud-based network, CARTONET platform that connects the field’s myriad devices to share the 3D image files into laptops, tablets, etc.
The global electrophysiology market is set to expand its scope in the forecast period, as a result of the rising prevalence of cardiac arrhythmias. In addition to this, the escalating demand for minimally invasive cardiac therapies, increasing adoption of the electrophysiology interventions, along with the incoming advanced technologies are propelling the growth of the market.
Electrophysiology Market: Segmentation
Product Type
- Electrophysiology Laboratory Devices
- 3D Mapping Systems
- Electrophysiology Recording Systems
- Radiofrequency (RF) Ablation Systems
- Intracardiac Echocardiography (Ice) Ultrasound Imaging Systems
- Cardiac Stimulators
- Others
- Electrophysiology Ablation Catheters
- Cryoablation Electrophysiology Catheters
- Radiofrequency (RF) Ablation Catheters
- Irrigated Tip RF Ablation Catheters
- Laser Ablation Catheters
Expand Operations in the Future To Get Requisite Details, Ask for a Custom Report@ https://www.futuremarketinsights.com/customization-available/rep-gb-12402
- Electrophysiology Diagnostic Catheters
- Conventional Electrophysiology Diagnostic Catheters
- Advanced Electrophysiology Diagnostic Catheters
- Ultrasound Electrophysiology Diagnostic Catheters
- Access Devices
Indication
- Atrial Fibrillation
- Atrial Flutter
- Wolff-Parkinson-White Syndrome (WPW)
- Atrioventricular Nodal Reentry Tachycardia (AVNRT)
- Ventricular tachycardia (VT)
- Others
End-User
- Hospitals
- Cardiac Catheterization Laboratories
- Ambulatory Surgery Centers
Explore Wide-ranging Coverage of FMI’s Healthcare Landscape:
Amniotic Membranes Market: The global amniotic membranes market size is likely to touch a valuation of around US$ 1.4 Bn in 2022. Further, with rising adoption of amniotic membranes for various purposes in ophthalmology, the total sales of amniotic membranes are slated to grow at an impressive CAGR of 9.0% between 2022 and 2028, totalling over US$ 2.3 Bn by the end of 2028.
Digital Radiography Detectors Market: The digital radiography detectors market is valued at US$ 2.13 Bn in 2022. The market is advancing at an average pace with a CAGR of 6.1% through 2026 to reach a valuation of US$ 2.7 Bn. The worldwide market for digital radiography detectors is highly concentrated, with large competitors such as Varex Imaging Corporation and Trixell accounting for about 47% of the market share.
Sepsis Diagnostics Market: The global sepsis diagnostics market is expected to record a CAGR of 8.1% between 2023 and 2033. In 2023, the market is estimated to be valued at US$ 561.2 million. The valuation is expected to cross US$ 1.2 billion by 2033..
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
